In this podcast, PPD expert Cathy Vrentas discusses how to leverage bioanalytical assays for gene therapy programs, key considerations in the development of these assays, and how the unique nature of gene therapies impact the development and maintenance of bioanalytical assays.

Speaker: Catherine (Cathy) Vrentas, senior research scientist, PPD® Laboratories bioanalytical lab